Entity
  • G.CLIPS biotech

    Created in 2020
  • BETA

    Up & running (A)
    Existing signals show a regular activity
  • Social networks

    870
  • Activities

  • Technologies

  • Entity types

  • Location

    31670 Labège, France

    Labège

    France

  • Employees

    Scale: 2-10

    Estimated: 8

  • SIREN

    885068460
  • Engaged corporates

    12
    2 6
  • Added in Motherbase

    1 year, 6 months ago
Description
  • Value proposition

    ENABLING TECHNOLOGY FOR THERAPEUTICS TARGETING MEMBRANE PROTEINS


    G.CLIPS biotech created the first enabling technology to unravel the potential of drug and antibody candidates on pathology-like format membrane proteins to be used in screening efforts, characterization, structural studies, mechanism of action, pharmacological profiling and target validation.
    We offer a unique technology to express, stabilize, select and validate membrane proteins as targets based on proprietary G.Screen® Platform.

    G.Mixes®
    G.Select® Assay
    G.Lipidomics®
    G.Validation® Assay

    We provide tailor-made services to pharma, biotech and animal health companies targeting membrane proteins (GPCRS, Receptors, Transmebrane Proteins) that would like to ascertain the necessary environment and conformation stabilization for their targets at all steps of development.
    G.CLIPS biotech works on solutions in early discovery steps allowing targets to be in a pathology-like format for screening efforts, immunizations and in vitro testing.

    membrane proteins, drug targets, protein stabilisation, in vitro, and in cellulo

  • Original language

    ENABLING TECHNOLOGY FOR THERAPEUTICS TARGETING MEMBRANE PROTEINS


    G.CLIPS biotech created the first enabling technology to unravel the potential of drug and antibody candidates on pathology-like format membrane proteins to be used in screening efforts, characterization, structural studies, mechanism of action, pharmacological profiling and target validation.
    We offer a unique technology to express, stabilize, select and validate membrane proteins as targets based on proprietary G.Screen® Platform.

    G.Mixes®
    G.Select® Assay
    G.Lipidomics®
    G.Validation® Assay

    We provide tailor-made services to pharma, biotech and animal health companies targeting membrane proteins (GPCRS, Receptors, Transmebrane Proteins) that would like to ascertain the necessary environment and conformation stabilization for their targets at all steps of development.
    G.CLIPS biotech works on solutions in early discovery steps allowing targets to be in a pathology-like format for screening efforts, immunizations and in vitro testing.

  • Home - G.CLIPS BIOTECH

    Pathology-like targets for drug & antibody discovery - Quick decision tool for conditions of membrane proteins stabilization in specific conformation & environment

  • https://gclips-biotech.com/
Corporate interactions BETA
Corporate TypeTweets Articles
Toulouse Tech Transfer Toulouse Tech Transfer
Other

18 Jan 2024


Ville de Toulouse
Ville de Toulouse
Government Administration, French metropolis
Ville de Toulouse
Government Administration, French metropolis
Other

18 Jan 2024


Aerospace Valley
Aerospace Valley
Public business cluster, French Cluster, Aviation and Aerospace Component Manufacturing
Aerospace Valley
Public business cluster, French Cluster, Aviation and Aerospace Component Manufacturing
Other

18 Jan 2024


CEA
CEA
Research
CEA
Research
Other

18 Jan 2024


Créalia Occitanie
Créalia Occitanie
Civic and Social Organizations
Créalia Occitanie
Civic and Social Organizations
Other

30 Sep 2024


Lyonbiopôle Auvergne-Rhône-Alpes
Lyonbiopôle Auvergne-Rhône-Alpes
Public business cluster, Biotechnology, French Cluster, Biotechnology Research
Lyonbiopôle Auvergne-Rhône-Alpes
Public business cluster, Biotechnology, French Cluster, Biotechnology Research
Other

12 Oct 2023


Région Auvergne-Rhône-Alpes
Région Auvergne-Rhône-Alpes
National and local authorities, Government Administration
Région Auvergne-Rhône-Alpes
National and local authorities, Government Administration
Other

12 Oct 2023


Nubbo, Incubateur à mission
Nubbo, Incubateur à mission
Business Consulting and Services
Nubbo, Incubateur à mission
Business Consulting and Services
Other

10 Oct 2024


France Biotech
France Biotech
Startup accelerator & VC, Biotechnology, Biotechnology Research
France Biotech
Startup accelerator & VC, Biotechnology, Biotechnology Research
Other

31 May 2023


Eurobiomed
Eurobiomed
Public business cluster, Biotechnology, French Cluster, Biotechnology Research
Eurobiomed
Public business cluster, Biotechnology, French Cluster, Biotechnology Research
Other

29 Oct 2024


Similar entities
Loading...
Loading...
Social network dynamics